-
-
-
-
-
公开(公告)号：KR101376184B1
公开(公告)日：2014-03-25
申请号：KR1020110145925
申请日：2011-12-29
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: C07K16/08 , A61K39/395 , C12N5/07
Abstract: 본발명은분리된벌 바이러스를산란계에주입하여얻어지는난황항체의제조방법및 이를통해얻어지는벌 바이러스난황항체에관한것이다. 또한본 발명은상기난황항체를포함하는벌 바이러스방제용조성물및 이를이용한벌 바이러스방제방법에관한것이다.
-
Patent Agency Ranking
公开(公告)号：KR1020130077278A
公开(公告)日：2013-07-09
申请号：KR1020110145900
申请日：2011-12-29
Applicant: 대한민국(농림축산식품부 농림축산검역본부장)
IPC: A61K39/395 , A61P33/00
CPC classification number: A61K39/3955 , A61K2039/552 , Y10S424/826
Abstract: PURPOSE: A composition for toxoplasma strongylosis prevention and treatment is provided to be used on the toxoplasma strongylosis prevention and treatment by lowering infection and removing toxoplasma strongylosis without concern for toxicity and antibiotic resistance. CONSTITUTION: A composition for toxoplasma strongylosis prevention and treatment comprises an immunoglobulin yolk obtained through inoculating the toxoplasma strongylosis antigen to an egg. The antigen comprises an additional adjuvant. The immunoglobulin yolk is included to 260-1350 micrograms/milliliters. The treatment method is to inoculate the composition containing pharmaceutically effective amount of immunoglobulin yolk to a mammal. [Reference numerals] (AA) Survival rate (%)
Abstract translation: 目的：预防和治疗弓形体弓形虫病的组合物用于通过降低感染和去除弓形体强病毒而不受毒性和抗生素耐药性的预防和治疗弓形虫病。 构成：预防和治疗弓形体强毒素组合物包括通过将强毒素弓形虫病抗原接种到卵中获得的免疫球蛋白卵黄。 抗原包含另外的佐剂。 将免疫球蛋白蛋黄包含在260-1350微克/毫升中。 处理方法是将含有药学有效量的免疫球蛋白蛋白的组合物接种到哺乳动物。 （附图标记）（AA）存活率（％）
-
-
-
-
-
-
Search Results
12
records
(took 0.018 seconds)
